Our study is the first large population-based study investigating the association of six genetic variants increasing (PNPLA3, TM6SF2, GCKR, MBOAT7) and two genetic variants decreasing (PPP1R3B, HDS17B13) the risk of NAFLD. This evidence concerns the gene PPP1R3B and metabolic dysfunction-associated steatotic liver disease.